Clinical Trial Update: Effect of Dapagliflozin on Myocardial and Renal Function Following Aortic Valve Stenosis Intervention [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 trial investigating the effect of dapagliflozin on myocardial and renal function after aortic valve intervention.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aortic Stenosis
• Left Ventricular Hypertrophy

Drugs mentioned

• Dapagliflozin (dapagliflozin)

Snippet

Sponsor: University of Aarhus | Conditions: Aortic Stenosis, Left Ventricle Hypertrophied | Phase 2, Phase 3 | Status: UNKNOWN